PROCEPT BioRobotics Corporation

NASDAQ:PRCT

Medical - Devices

Healthcare
$25.18 +0.89%

+$0.19 today

Market cap
$1.45B
Beta
0.85
P/E (TTM)
-11.6
EPS (TTM)
-$1.81
52W Low $19.35High $62.17

Volume 2.05M

Average 1.46M

PRCT Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

PROCEPT BioRobotics CorporationNASDAQ: PRCT

Total Equity · Q1 FY2026 · quarter ended Mar 2026

Total equity falls 10.7% from a year ago

Total equity stood at $347.67M at the end of Q1 FY2026, down 10.7% from a year earlier and down 5.0% from the prior quarter. Over 3 fiscal years it compounded at +22.9% a year.

Context

  • Total equity amounted to 71.4% of total assets at the end of Q1 FY2026, down 3.5 pp from a year earlier.
  • Total equity increased in 2 of the last 3 fiscal years.

What to watch

Whether total equity keeps falling in the next quarterly balance sheet after a -10.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$347.67M-5.0% QoQ
Last fiscal yearDec 2025
$365.87M-9.0% YoY
Year agoMar 2025
$389.16M-10.7% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-10.7%——
1 year-9.0%——
3-year CAGR+22.9%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
365.87M USD
Year-over-year change
-9.0%
4-year CAGR
+8.2%

Total Equity vs competitors

How PRCT compares with its peers on the latest reported figures

  • PRCT's Mar 2026 total equity of $347.67M is the highest of the 5 companies compared; the peer median is $36.68M.
  • Its year-over-year change of -10.7% is the 4th highest of 5, against a peer median of +14.4%.
  • Total equity amounts to 71.4% of total assets for PRCT, versus a peer median of 40.2%.
PRCT Competitors Peer median
Total Equity for PRCT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PRCTPROCEPT BioRobotics CorporationMar 2026$347.67M -10.7%+22.9%71.4%
MBOTMicrobot Medical Inc.Mar 2026$74.11M +156.0%+119.9%94.9%
SSIISS Innovations International, Inc.Mar 2026$54.52M +34.4%—60.2%
CLPTClearPoint Neuro, Inc.Mar 2026$18.84M -5.7%-8.8%20.2%
FOCLEDAP TMS S.A. American Depositary SharesMar 2026$10.1M -72.9%-36.7%14.0%
Peer median (excluding PRCT) $36.68M+14.4%-8.8%40.2%

Competitors are the stored peer set for PRCT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents304.32M222.64M257.22M333.73M286.5M
Short-term Investments00000
Net Receivables4.46M15.27M48.38M83.5M83.53M
Inventory13.15M28.54M39.76M56.17M70.69M
Other Current Assets3.41M6.18M5.21M8.45M9.65M
Total Current Assets326.17M272.63M350.57M481.84M450.38M
Property, Plant & Equipment (Net)8.32M32.14M48.99M45.65M47.94M
Goodwill00000
Intangible Assets1.75M1.48M1.2M932K709K
Long-term Investments777K3.04M3.04M3.04M3.04M
Tax Assets00000
Other Non-current Assets051K919K2.56M6.02M
Total Non-current Assets10.85M36.7M54.15M52.18M57.7M
Total Assets337.02M309.33M404.72M534.02M508.08M
Account Payables2.03M9.39M13.5M10.03M17.29M
Short-term Debt2.11M2.13M1.68M1.91M0
Tax Payables515K829K1.73M2.07M0
Deferred Revenue1.02M2.86M5.66M9.57M13.05M
Other Current Liabilities4.61M7.47M8.2M10.09M35.46M
Total Current Liabilities16.24M35.29M45.93M53.13M65.8M
Long-term Debt50M51.21M51.34M51.47M51.62M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.7M1.78M517K324K24.8M
Total Non-current Liabilities53.69M76.97M78.04M78.66M76.42M
Total Liabilities69.93M112.26M123.97M131.8M142.21M
Common Stock00000
Retained Earnings(261.52M)(348.68M)(454.57M)(545.99M)(641.56M)
Accumulated OCI(54K)(6K)84K114K37K
Other Stockholders Equity00000
Minority Interest00000
Total Equity267.09M197.07M280.75M402.22M365.87M
Total Debt54.1M77.32M79.2M80.25M51.62M
Net Debt(250.22M)(145.32M)(178.02M)(253.48M)(234.89M)

PROCEPT BioRobotics Corporation

NASDAQ:PRCT

Intrinsic Alpha fair value

Locked

Current Price

$25.18

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.